702 filings
Page 19 of 36
8-K
crbqdqt
10 Dec 14
Acorda Announces Initiation of Phase 3 Trial of CVT-301 in Parkinson’s Disease
12:00am
8-K
3heviu
30 Oct 14
Results of Operations and Financial Condition
12:00am
8-K
bjau44h
24 Oct 14
Acorda Therapeutics Completes Acquisition of Civitas Therapeutics
12:00am
8-K
al7j4 82tadqx
26 Sep 14
Acorda Therapeutics to Acquire Civitas Therapeutics
12:00am
CT ORDER
2ydw8banbjkkp17du7
26 Aug 14
Confidential treatment order
12:00am
CT ORDER
mk20dr
7 Aug 14
Confidential treatment order
12:00am
8-K
q2qa2jb92s33ew
31 Jul 14
Acorda Therapeutics Reports Second Quarter 2014 Financial Results
12:00am
8-K
1yhx4zbz6kc5dmuakq
9 Jul 14
Other Events
12:00am
8-K
7ly dxfwwf78
26 Jun 14
Other Events
12:00am
8-K
0o06q
23 Jun 14
Entry into a Material Definitive Agreement
12:00am
424B5
1m4jtmxypya 18q9
19 Jun 14
Prospectus supplement for primary offering
12:00am
8-K
yt4s7ho4jy2ef0fle
18 Jun 14
Other Events
12:00am
FWP
9rzt5
18 Jun 14
Free writing prospectus
12:00am
424B5
pyi64908vd6kobu3xaky
16 Jun 14
Prospectus supplement for primary offering
12:00am
8-K
f94r ck2jr2xi
16 Jun 14
Acorda Therapeutics Announces Public Offering
12:00am
S-3ASR
8ypyuh174wmo z7
16 Jun 14
Automatic shelf registration
12:00am
8-K
gxx88hdvm7g3rba
10 Jun 14
Submission of Matters to a Vote of Security Holders
12:00am
8-K
tplbi
14 May 14
Acorda Therapeutics Appoints Andrew Hindman as Chief Business Development Officer
12:00am